Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Experts weigh value of weight loss, new drugs against adverse events
• Screening for type 1 diabetes: not ready for clinical implementation
• Do psychiatric adverse events outweigh the potential metabolic effects of some drugs?
• Should we be screening for type 1 diabetes?
• Idiopathic foot injury in a patient with diabetes Patris Toney, DPM, MPH
• When the ‘fudge factor’ causes hypoglycemia Ronald Tamler, MD, PhD, MBA
• The cost of physical inactivity Mary M. Austin
• Bioidentical … to what? Donald A. Bergman, MD
• Effects of eating disorders and diabetes Belinda P. Childs, ARNP, MN, CDE, BC-ADM
• Endocrine University welcomed a new group of young endos Emily J. Tan, MD
• The shoe-fitting fluoroscope: a little known application of the X-ray Leah Lawrence
• The case of the relapsing pituitary enlargement with galactorrhea Stephanie L. Lee, MD, PhD, ECNU
• Gasoline, crack cocaine and health care Richard O. Dolinar, MD
• Anti-inflammatory drug improved glycemia in obese young adults
• Connective tissue growth factor associated with microalbuminuria development
• Depression linked to low testosterone levels
• Insulin resistance higher among women with PCOS
• Encourage lean diet for patients with diabetes, metabolic syndrome
• Low-income Hispanic patients less likely to monitor blood glucose
• Low TSH and risk for osteoporosis: a review
• T3: Not just for treating the thyroid
• Thyroid hormone has multiple effects on cholesterol synthesis and metabolism
• ‘Engage the village’ to reverse childhood obesity Kathleen Gold, RN, MSN, CDE
• “Diabetes for Dummies” author pens smart books for patients
• Review of exenatide for the treatment of type 2 diabetes James R. Taylor, PharmD, CDE